Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mallinckrodt Plc Ordinary Share (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,799,513
  • Shares Outstanding, K 83,080
  • Annual Sales, $ 3,222 M
  • Annual Income, $ 2,134 M
  • 36-Month Beta 1.20
  • Price/Sales 0.56
  • Price/Cash Flow 1.35
  • Price/Book 0.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.20 +19.01%
on 06/27/18
22.18 -2.34%
on 07/19/18
+1.47 (+7.28%)
since 06/20/18
3-Month
11.65 +85.92%
on 05/04/18
22.18 -2.34%
on 07/19/18
+7.90 (+57.41%)
since 04/20/18
52-Week
11.65 +85.92%
on 05/04/18
49.12 -55.90%
on 07/25/17
-25.05 (-53.63%)
since 07/20/17

Most Recent Stories

More News
The Short Playbook on TSLA, HLF and QCOR

The Short Playbook on TSLA, HLF and QCOR

NFLX : 361.05 (-0.87%)
AAPL : 191.44 (-0.23%)
TSLA : 313.58 (-2.08%)
HLF : 52.65 (+0.27%)
MNK : 21.66 (-1.10%)
The Short Playbook on TSLA, HLF and QCOR

The Short Playbook on TSLA, HLF and QCOR

NFLX : 361.05 (-0.87%)
AAPL : 191.44 (-0.23%)
TSLA : 313.58 (-2.08%)
HLF : 52.65 (+0.27%)
MNK : 21.66 (-1.10%)
After Yesterday's Rally of 1.05% Shares Could Potentially Pullback

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $20.36 to a high of $21.36. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $21.25...

MNK : 21.66 (-1.10%)
New Health Economic Data on Mallinckrodt's OFIRMEV® (Acetaminophen) Injection Published in Journal of Knee Surgery

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced two retrospective analyses that provide health economic insights on use of OFIRMEV® (acetaminophen) injection...

MNK : 21.66 (-1.10%)
Should Value Investors Consider Mallinckrodt (MNK) Stock?

Is Mallinckrodt (MNK) a great pick from the value investor's perspective right now? Read on to know more.

MNK : 21.66 (-1.10%)
Shares of MNK Up 21.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Mallinckrodt (NYSE:MNK) on May 15th, 2018 at $15.78. In approximately 2 months, Mallinckrodt has returned 21.46% as of today's recent price of $19.16.

MNK : 21.66 (-1.10%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endo Internation (ENDP , NKTR , MNK , AKRX , LCI )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

ENDP : 11.15 (-0.62%)
MNK : 21.66 (-1.10%)
NKTR : 48.73 (-0.71%)
Mallinckrodt Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar® Gel (Repository Corticotropin Injection) Achieves its Enrollment Target

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has completed enrollment of the company's ongoing Phase 4 clinical trial of H.P. Acthar® Gel for Rheumatoid...

MNK : 21.66 (-1.10%)
Mallinckrodt Has Returned 19.0% Since SmarTrend Recommendation (MNK)

SmarTrend identified an Uptrend for Mallinckrodt (NYSE:MNK) on May 15th, 2018 at $15.78. In approximately 1 month, Mallinckrodt has returned 19.05% as of today's recent price of $18.78.

MNK : 21.66 (-1.10%)
After Yesterday's Decline of 3.78%, Mallinckrodt Offers Investors Better Value

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $18.42 to a high of $19.66. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $18.67...

MNK : 21.66 (-1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MNK with:

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 22.19
1st Resistance Point 21.92
Last Price 21.66
1st Support Level 21.46
2nd Support Level 21.27

See More

52-Week High 49.12
Fibonacci 61.8% 34.81
Fibonacci 50% 30.38
Fibonacci 38.2% 25.96
Last Price 21.66
52-Week Low 11.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar